meglumine and EBV Infections

meglumine has been researched along with EBV Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bashkina, OA; Engibarian, KZh; Galimzianov, KhM; Kasymova, EB; Rodina, LP; Romantsov, MG1
Bashkina, OA; Chanpalova, LS; Engibaryan, KZh; Galimzyanov, KhM; Kasymova, EB; Kovalenko, AL; Rodina, LP1
Abderrahim, E; Bacha, MM; Bahloul, A; Ben Abdallah, T; Ben Maïz, H; Chaouech, D; Cherif, M; Khaled, S; Kheder, A; Ounissi, M; Rajhi, H; Trabelsi, S; Turki, S; Znaidi, N1

Trials

1 trial(s) available for meglumine and EBV Infections

ArticleYear
[Reamberin optimizes drug therapy in children with acute Epstein-Barr viral infection].
    Eksperimental'naia i klinicheskaia farmakologiia, 2014, Volume: 77, Issue:1

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Infant; Inflammation; Liver; Male; Meglumine; Protein Biosynthesis; Succinates

2014

Other Studies

2 other study(ies) available for meglumine and EBV Infections

ArticleYear
[PHARMACOLOGICAL CORRECTION OF METABOLIC DISORDERS IN CHILDREN WITH ACUTE EPSTEIN--BARR VIRAL INFECTION].
    Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:1

    Topics: Acute Disease; Adolescent; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Male; Meglumine; Metabolic Diseases; Succinates

2016
[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
    Nephrologie & therapeutique, 2011, Volume: 7, Issue:6

    Topics: Adult; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antiprotozoal Agents; Antiviral Agents; Epstein-Barr Virus Infections; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Lymphoproliferative Disorders; Male; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Postoperative Complications; Remission Induction; Rituximab; Sirolimus

2011